Who we serve

The funding problem looks different depending on who has it. A research university choosing between limited submissions and a seed-stage biotech deciding whether to take a grant or a round are not doing the same thing, and generic advice serves neither.

Research Universities

Federal funding strategy for research universities — portfolio-level programme selection, limited submission triage and agency engagement.

  • Limited submissions
  • Centre-scale coordination
  • Research development capacity
Read more

Academic Medical Centers

Federal funding strategy for academic medical centres and schools of medicine — NIH programme strategy, multi-PI centres and translational work.

  • Institute and mechanism selection
  • Multi-PI and centre awards
  • The translational gap
Read more

Life Sciences and Biotechnology Companies

SBIR, STTR and venture strategy for biotech and medical device companies — non-dilutive funding first, then the raise it makes possible.

  • Sequencing money
  • Phase I as a means, not an end
  • Commercialisation is scored
Read more

Start with a conversation

Tell us what you are working on and where the funding gap is. If we are not the right people for it, we will say so and point you at who is.